Morrisville, NC (PRWEB) October 19, 2009
Centice Corporation, a pioneer in drug verification and safety products, announced today that Arthur Bergens, Centice Corporation's Chief Financial and Operating Officer, was named as a 2009 Top CFO by Business Leader Media and BDO Seidman LLP. Winners were honored at an event on October 13, 2009 and they will be featured in the October 2009 issue of Business Leader magazine. This year the honorees for the 2009 Top CFOs were chosen from a record number of nominations.
Mr. Bergens came to Centice in January 2006. Since joining Centice, Mr. Bergens has been responsible for the design, implementation, and leadership of the financial, operations, IT, human resources, manufacturing and administrative functions at the company. In addition, he has been the point person for Centice in securing multiple debt and equity financings totaling over $23 million. He has also been instrumental in helping guide Centice to its recent launch of its initial product, PASS Rx®.
"Arthur has been with Centice almost four years. During that time, he has done a terrific job in building the financial, operational and administrative infrastructure for Centice. He has also been the key person in leading the company's successful fund-raising efforts. We are delighted to have him on our team and are very proud that he has been recognized as a 2009 Top CFO in the Research Triangle," said Scott Albert, Chairman of the Board and Chief Executive Officer of Centice.
Prior to joining Centice, Mr. Bergens has held CFO and other financial leadership roles with technology products and supply chain management companies that include Amkor Technology, Inc., Unitive Inc., and Modus Media International. Previously, he also spent about eight years with Ernst and Young.
About Centice Corporation:
Centice, founded in 2004 and headquartered in Morrisville, NC, is commercializing patented and patent-pending computational sensor and machine vision technology. The PASS Rx® pharmaceutical authentication sensor system improves the verification process for dispensed medications, thereby improving quality and optimizing workflow in the pharmacy. The company has received venture capital investments from The Aurora Funds, Inc., Novak Biddle Venture Partners, S-Group Direct Investments Ltd, Innovation Ventures LP, Fulcrum Financial Group, L.P. and other private investors. More information on Centice can be found at http://www.centice.com.